ArriVent BioPharma, Inc. (NASDAQ:AVBP) appears in 119 institutional 13F filings for the quarter ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 0 | 326,700 | 15.97% | $0.00 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 0 | 402,583 | 10.87% | $0.00 |
| INFINITUM ASSET MANAGEMENT, LLC | 31 Dec, 2025 | 0 | 255,000 | 6.59% | $0.00 |
| Barclays Plc | 31 Dec, 2025 | 0 | -42,284 | -24.66% | $0.00 |
| FMR LLC | 31 Dec, 2025 | 0 | 296,023 | 8.69% | $0.00 |
| HHLR ADVISORS, LTD. | 31 Dec, 2025 | 0 | -555,555 | -12.39% | $0.00 |
| ORBIMED ADVISORS LLC | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |
| Octagon Capital Advisors LP | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |
| Novo Holdings A/S | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |
| Sofinnova Investments, Inc. | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 0 | -160,265 | -7.90% | $0.00 |
| General Catalyst Group Management, LLC | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |
| State Street Corp | 31 Dec, 2025 | 0 | 64,352 | 6.26% | $0.00 |
| AIHC Capital Management Ltd | 31 Dec, 2025 | 0 | 644,788 | 0.00% | $0.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 0 | 37,231 | 5.20% | $0.00 |
| UBS Group AG | 31 Dec, 2025 | 0 | -46,681 | -9.38% | $0.00 |
| Goldman Sachs Group Inc | 31 Dec, 2025 | 0 | 310,587 | 71.91% | $0.00 |
| Point72 Asset Management, L.P. | 31 Dec, 2025 | 0 | 216,660 | 0.00% | $0.00 |
| HSG Holding Ltd | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |
| Rosalind Advisors, Inc. | 31 Dec, 2025 | 0 | 215,871 | 0.00% | $0.00 |